Tumor necrosis factor-α inhibitors and preeclampsia: assessing the evidence for risk reduction

被引：0
|
作者：
Tang, Wei-Zhen [1 ]
Xu, Wei-Ze [1 ]
Liu, Tai-Hang [1 ]
机构：
[1] Chongqing Med Univ, Sch Basic Med Sci, Dept Bioinformat, Chongqing, Peoples R China
来源：
JOURNAL OF HYPERTENSION | 2025年 / 43卷 / 01期
关键词：
PREGNANCY;
D O I：
10.1097/HJH.0000000000003880
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：181 / 182
页数：2
相关论文
共 50 条
  • [31] Safety and Tolerability of Tumor Necrosis Factor-α Inhibitors in Psoriasis: A Narrative Review
    Ashley L. Semble
    Scott A. Davis
    Steven R. Feldman
    American Journal of Clinical Dermatology, 2014, 15 : 37 - 43
  • [32] Myocardial expression of tumor necrosis factor-α and tumor necrosis factor-α converting enzyme in human myocarditis
    Satoh, M
    Nakamura, M
    Satoh, H
    Segawa, I
    Masuda, T
    Hiramori, K
    CIRCULATION, 1999, 100 (18) : 381 - 381
  • [33] Effects of tumor necrosis factor-α inhibitors on lung lesions with rheumatoid arthritis
    Inoue, KI
    Takano, H
    Yanagisawa, R
    Yoshikawa, T
    CHEST, 2003, 124 (01) : 413 - 414
  • [34] Frequency of Thrombocytopenia in Psoriasis Patients Treated With Tumor Necrosis Factor-α Inhibitors
    Chen, Meng
    Holland, Michael J.
    Mir, Mohsin R.
    Wong, Michael G.
    Kelley, Brian P.
    Grim, Kelli D.
    Bhuchar, Sunaina S.
    Hsu, Sylvia
    JOURNAL OF DRUGS IN DERMATOLOGY, 2011, 10 (03) : 280 - 284
  • [35] Fullerenes and their derivatives as inhibitors of tumor necrosis factor-α with highly promoted affinities
    Gaoyin Wu
    Xuejiao J. Gao
    Joonkyung Jang
    Xingfa Gao
    Journal of Molecular Modeling, 2016, 22
  • [36] Cardiovascular event risk assessment in psoriasis patients treated with tumor necrosis factor-α inhibitors versus methotrexate
    Wu, Jashin J.
    Guerin, Annie
    Sundaram, Murali
    Dea, Katherine
    Cloutier, Martin
    Mulani, Parvez
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (01) : 81 - 90
  • [37] Reduced Cardiovascular Risk with Use of Methotrexate and Tumor Necrosis Factor-α Inhibitors in Patients with Rheumatoid Arthritis.
    Bozaite-Gluosniene, Rasa
    Tang, Xiaoqin
    Kirchner, H. Lester
    Antohe, Jana L.
    Morris, Stephanie J.
    Wasko, Mary Chester
    Bili, Androniki
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S279 - S280
  • [38] Tumor necrosis factor-α soluble receptor p55 (sTNFp55) and risk of preeclampsia in Peruvian women
    Sanchez, SE
    Zhang, CL
    Williams, MA
    Ware-Jauregui, S
    Larrabure, G
    Bazul, V
    Farrand, A
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2000, 47 (01) : 49 - 63
  • [39] Tumor necrosis factor-α and -β genetic polymorphisms as a risk factor in Saudi patients with schizophrenia
    Kadasah, Saeed
    Arfin, Misbahul
    Rizvi, Sadaf
    Al-Asmari, Mohammed
    Al-Asmari, Abdulrahman
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2017, 13 : 1081 - 1088
  • [40] Tumor necrosis factor-α and -β genetic polymorphisms as a risk factor in Saudi patients with vitiligo
    Al-Harthi, F.
    Zouman, A.
    Arfin, M.
    Tariq, M.
    Al-Asmari, A.
    GENETICS AND MOLECULAR RESEARCH, 2013, 12 (03) : 2196 - 2204
12345